Literature DB >> 33663475

Incidence of microcarcinoma and non-microcarcinoma in ultrasound-found thyroid nodules.

Zhi Chen1, Singla Sethiel Mosha2, Tong Zhang1, Ming Xu3, Yanli Li2, Zhuoqing Hu2, Weiqiang Liang4, Xiaoyi Deng2, Tingting Ou2, Ling Li5, Wangen Li6.   

Abstract

BACKGROUNDS: The incidence of thyroid nodules is increasing year by year around the world. However, ultrasound is not recommended as a screening test for the general population or patients with a normal thyroid on palpation by the American Association of Clinical Endocrinologists (AACE). In practice, some individuals with normal thyroid palpation have nodules that can just be found out by ultrasound. No studies have directly described the risk of nodules found by ultrasound or by palpation up to now. More evidence is needed to carry out for helping us balance the over diagnosis and missed diagnosis of malignant lesions. Therefore, we carried out a retrospective study to investigate the incidence of malignant lesions in ultrasound-found nodules in a large cohort.
METHODS: We conducted a retrospective analysis involving 2957 patients who underwent thyroid ultrasound evaluation and fine-needle aspiration (FNA) between Jan 2013 and Dec 2019. The cytologic examinations were analyzed based on the Bethesda system. For nodules suspected to be follicular neoplasm or other malignant tumors by cytological tests, patients were recommended for surgery and histopathology examinations.
RESULTS: Compared with palpation-found nodules, ultrasound-found nodules were presenting less as purely cystic nodules (10.1 % vs. 39.9 %, x2 = 355.69, p = 0.000), smaller size (17.5 ± 9.9 mm vs. 28.0 ± 12.5 mm, t = 23.876 p = 0.000), and higher TI-RADS score (5.5 ± 2.9 vs. 3.4 ± 3.3, t = 18.084, p = 0.000), respectively. More ultrasound-found nodules were diagnosed as carcinoma by histology examinations [136 (11.2 %) nodules found by ultrasound vs. 68 (3.9 %) by palpation, x2 = 59.737, p = 0.000], and 88 (64.7 %) nodules found by ultrasound were non-microcarcinoma. Among the malignant nodules confirmed by histopathology, a higher proportion of microcarcinoma was detected in ultrasound-found nodules [35.3 % (48/136) vs. 16.2 % (11/68), x2 = 8.183, p = 0.004].
CONCLUSIONS: In view of the results observed in our research, malignant nodules were more common in nodules screened out by ultrasound, and nearly two thirds of them were non-microcarcinoma. We suggest the recommendation against screening thyroid nodules by ultrasound needs to be re-evaluated.

Entities:  

Keywords:  Carcinomas; Screen; Thyroid nodules; Ultrasound

Year:  2021        PMID: 33663475      PMCID: PMC7934238          DOI: 10.1186/s12902-021-00700-1

Source DB:  PubMed          Journal:  BMC Endocr Disord        ISSN: 1472-6823            Impact factor:   2.763


  23 in total

1.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  Thyroid cancer: incidence and mortality trends in China, 2005-2015.

Authors:  Junyi Wang; Fangfang Yu; Yanna Shang; Zhiguang Ping; Li Liu
Journal:  Endocrine       Date:  2020-01-30       Impact factor: 3.633

3.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Freddie Bray; Christopher P Wild; Martyn Plummer; Luigino Dal Maso
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

5.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.

Authors:  Hyeyeun Lim; Susan S Devesa; Julie A Sosa; David Check; Cari M Kitahara
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

6.  The largest CAP-certified Chinese reference laboratory experience with the Bethesda system for reporting thyroid cytopathology: correlation with histologic and BRAF data.

Authors:  Baowen Zheng; Matthew A Zarka; Congde Chen; Jia You; Li Sun; Longwen Chen
Journal:  J Am Soc Cytopathol       Date:  2017-07-26

7.  Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk.

Authors:  Jin Young Kwak; Kyung Hwa Han; Jung Hyun Yoon; Hee Jung Moon; Eun Ju Son; So Hee Park; Hyun Kyung Jung; Ji Soo Choi; Bo Mi Kim; Eun-Kyung Kim
Journal:  Radiology       Date:  2011-07-19       Impact factor: 11.105

8.  Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: multicentric retrospective study in China.

Authors:  JianQiao Zhou; YanYan Song; WeiWei Zhan; Xi Wei; Sheng Zhang; RuiFang Zhang; Ying Gu; Xia Chen; Liying Shi; XiaoMao Luo; LiChun Yang; QiaoYing Li; BaoYan Bai; XinHua Ye; Hong Zhai; Hua Zhang; XiaoHong Jia; YiJie Dong; JingWen Zhang; ZhiFang Yang; HuiTing Zhang; Yi Zheng; WenWen Xu; LiMei Lai; LiXue Yin
Journal:  Endocrine       Date:  2020-08-27       Impact factor: 3.633

9.  Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.

Authors:  Samantha Tam; Moran Amit; Mongkol Boonsripitayanon; Naifa L Busaidy; Maria E Cabanillas; Steven G Waguespack; Neil D Gross; Elizabeth G Grubbs; Michelle D Williams; Stephen Y Lai; Erich M Sturgis; Mark E Zafereo
Journal:  Thyroid       Date:  2018-07-27       Impact factor: 6.568

10.  Association between thyroid nodule size and malignancy rate.

Authors:  M Jinih; F Faisal; K Abdalla; M Majeed; A A Achakzai; C Heffron; J McCarthy; H P Redmond
Journal:  Ann R Coll Surg Engl       Date:  2019-12-23       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.